SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

WEEDCOIN is trending amidst community excitement over recent federal cannabis regulatory changes, including reclassification and the elimination of the 280E tax. The strong "Green Wave" sentiment positions the token as a primary beneficiary and a liquidity driver within the Solana ecosystem, with holders actively discussing its role in disrupting traditional pharmaceutical industries and promoting decentralized natural medicine.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop continues to trend with significant community debate surrounding CEO Ryan Cohen's strategic silence and the stock's recent performance, prompting a mix of frustration and unwavering conviction among "apes." Amidst persistent short interest and discussions of broader market manipulation, investors are looking to the upcoming year and the 2026 warrant expiration as potential catalysts for a major shift. Many believe the company's substantial cash reserves underscore its long-term value despite current challenges.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is a major talking point as it consolidates around key price levels, sparking a fierce debate between those expecting an imminent surge to new highs and others predicting a significant downturn. Community sentiment is divided, with bullish arguments pointing to institutional accumulation and the end of tax-loss selling, contrasted by bearish concerns over market manipulation and potential regulatory shifts.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is a top trending stock as investors eagerly await Q4 delivery numbers, which are igniting a fierce debate between bulls and bears. While some anticipate stellar results, a significant short squeeze, and the promise of a Cybercab future, others fear declining sales, market share loss to competitors like BYD, and continued overvaluation. This sharp divergence in sentiment reflects fundamental concerns about the company's EV business against its ambitious long-term AI and robotics vision.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is heavily trending as futures indicate a strong rebound from recent market dips, prompting debate within the community regarding a genuine new year rally versus a potential "bull trap." This momentum is significantly influenced by a recent large Fed liquidity injection and ongoing speculation around future interest rate adjustments, even as some investors highlight cautionary treasury market signals.

Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Rockville, MD.

Sensei Biotherapeutics Inc

Sensei Biotherapeutics (SNSE) is trending as the community speculates on its ongoing strategic review, with the company exploring a potential sale or merger while holding substantial cash and a remarkably low share float. Traders are actively discussing the stock's significant short squeeze potential and its history as a volatile runner, drawing comparisons to other micro-cap movers. This confluence of factors, despite operational shifts, fuels anticipation for a major price movement.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai (BBAI) is trending following its recently finalized acquisition of Ask Sage, an AI platform designed for secure government and defense use. The community is actively discussing the strategic potential for new government contracts, such as with the TSA, while simultaneously navigating a postponed shareholder vote on authorized shares, which stirs debate regarding future funding and potential dilution.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending with significant community debate as markets transition into the new year, following a period of volatility some attribute to year-end tax loss selling. Sentiment is split between anticipating a strong rebound driven by rallying futures and continued AI sector strength, and warnings of potential market corrections or manipulation.

Alchemy Investments Acquisition Corp. 1 is a blank check company, which engages in merger, share exchange, asset acquisition, share purchase, and reorganization or similar business combination. The company was founded on October 27, 2021 and is headquartered in Newark, DE.

Alchemy Investments Acquisition Corp 1 - Ordinary Shares - Class A

Alchemy Investments Acquisition Corp 1 (ALCY) is trending due to its low float status, leading to strong community speculation about significant short-term appreciation. Traders are actively comparing it to recent high-performing SPACs, anticipating a rapid surge driven by limited circulating shares. The discussion highlights a broader rotation into such low-float plays across the market, fueled by perceptions of a "SPAC bubble" opportunity.

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions (INBS) is experiencing high trading volume following a new manufacturing partnership with Syrma Johari, aimed at scaling production for its drug screening reader ahead of anticipated U.S. market entry. However, community sentiment is highly polarized, with optimism for long-term growth and increased capacity countered by significant concerns regarding recent share dilution from a private placement and warrant issuance.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Best Biotech Stocks To Follow Now - January 1st

Vertex Pharmaceuticals, Danaher, Abivax, Moderna, and United Therapeutics are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of...

VIRGINIA RETIREMENT SYSTEMS ET Al Makes New Investment in Vertex Pharmaceuticals Incorporated $VRTX

VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the third quarter, according to its most recent filing with the...

25,734 Shares in Vertex Pharmaceuticals Incorporated $VRTX Bought by Generate Investment Management Ltd

Generate Investment Management Ltd bought a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the 3rd quarter, according to its most recent filing with the...

Ethic Inc. Has $5.47 Million Stock Position in Vertex Pharmaceuticals Incorporated $VRTX

Ethic Inc. boosted its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 21.5% during the third quarter, according to the company in its most recent filing with...

Vertex Pharmaceuticals (VRTX) Dips More Than Broader Market: What You Should Know

In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $453.74, marking a -1.31% move from the previous day.

Here's Why Vertex Pharmaceuticals (VRTX) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Best Biotech Stocks To Consider - December 29th

Danaher, Vertex Pharmaceuticals, and Abivax are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly traded companies that...

Leerink Partners Boosts Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target to $525.00

Leerink Partners lifted their price objective on Vertex Pharmaceuticals from $456.00 to $525.00 and gave the stock an "outperform" rating in a report on Monday...

Best Biotech Stocks To Follow Now - December 28th

Danaher, Moderna, Vertex Pharmaceuticals, Cidara Therapeutics, United Therapeutics, Medpace, and argenex are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool...

Burney Co. Reduces Position in Vertex Pharmaceuticals Incorporated $VRTX

Burney Co. cut its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 83.1% during the third quarter, according to the company in its most recent Form 13F filing with the...

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Current Price	$453.36
Prev Close	$453.74
Open	$451.75
Dividend Yield	0.00%
50-Day Moving Average	$436.81
Beta	0.54
Avg. Volume	1.46M
PE Ratio	31.95

52-Week High	$519.68
52-Week Low	$362.50
Market Capitalization	$115.03B
EPS (Annual)	-$2.08
Price to Book	6.65
Revenue Per Employee	$1.8M
Enterprise Value/EBITDA	N/A

VRTX
Vertex Pharmaceuticals, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest VRTX News

VRTXVertex Pharmaceuticals, Inc.